A phase 1 randomised clinical trial of a novel Nipah virus vaccine, led by US researchers, may soon pave the way to prevent ...

The advisory comes after the implementation of Phase IV of the Graded Response Action Plan (GRAP) in the Delhi-NCR region amid deteriorating air quality.

Published today in Clinical Cancer Research, findings from a study led by investigators at the Vall d'Hebron Institute of ...

Why do parasites harm their hosts? That's a question evolutionary biologists ask as they try to predict how a parasite might ...

A phase 1 randomised clinical trial of a novel Nipah virus vaccine, led by US researchers, may soon pave the way to prevent ...

The first signs of victory in any conflict are often not on the battlefield but in the narrative space. The side that ...

Ceramic resonators offer an attractive alternative to quartz crystals for stabilizing oscillation frequencies in many ...

Up to $54.3 million CEPI investment aims to help advance Moderna’s H5 pandemic influenza vaccine candidate to licensure Partnership strengthens global preparedness against a significant pandemic ...

Teclistamab (Tecvayli) is an off-the-shelf first-in-class bispecific monoclonal antibody shown in the MajesTEC-1 trial to ...

The advocacy for better IPC follows the COVID-19 experience, which exposed deep weaknesses in Nigeria’s health system, ...

The monotherapy trial suggested a confirmed overall-response rate of 46% and a disease-control rate of 93%. In combination with Keytruda, the confirmed overall-response rate was 71% and the ...

Using drugs that inhibit enzymes called CDK4/6 and CDK2 extends the G1 phase of the cell cycle and helps to slow the growth of drug-resistant breast cancer.